Olainfarm forecasts 10% sales growth
This article was originally published in Scrip
Executive Summary
Latvia's second largest pharmaceutical manufacturer Olainfarm plans to increase sales by 10% to Ls24.5 million ($42.4 million) and increase profits by 15% to Ls2.7 million in the current year, its management board has said. However, it noted that the company's main markets have not yet fully recovered from the recent financial and economic crisis.